BG
Q4 2026 EPS Estimate
$2.45
Nov 4, 2026 · Reports before open
Revenue Estimate
$23.31B
FY2026E EPS$9.49
FY2027E EPS$11.16

Analyst Sentiment

Wall St. Consensus
Buy
24 analysts·High coverage
72
Score
21 Buy (88%)3 Hold (13%)0 Sell (-1%)
Rating Breakdown
Strong Buy
00%
Buy
2188%
Hold
313%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear
$130.00
+14.9%
Consensus
$150.00
+32.6%
Bull
$150.00
+32.6%
12-Month Target Range24 analysts
$130.00$150.00$150.00
Current $113.16Consensus
Current Price
$113.16
Upside to Consensus
$36.84

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)
FY2027
Rev+3.27%
EPS+17.70%
FY2028
Rev-0.46%
EPS+6.54%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
MetricFY2026EFY2027EFY2028E
Revenue Avg$92.03B$95.04B$94.60B
Low$90.99B$93.87B$94.10B
High$93.06B$96.21B$95.11B
EBITDA Avg$4.53B$4.68B$4.66B
Low$4.48B$4.62B$4.64B
High$4.58B$4.74B$4.69B
EBIT Avg$3.80B$3.93B$3.91B
Low$3.76B$3.88B$3.89B
High$3.85B$3.98B$3.93B
Net Income Avg$1.58B$1.86B$1.98B
Low$1.57B$1.85B$1.88B
High$1.58B$1.87B$2.04B
EPS Avg$9.49$11.16$11.89
Low$9.46$11.10$11.31
High$9.52$11.23$12.28
Analysts (Rev / EPS)4 / 45 / 43 / 1
Quarterly
MetricQ3 2026Q4 2026Q1 2027Q2 2027Q3 2027Q4 2027Q1 2028Q2 2028
Revenue Avg$23.09B$23.71B$22.62B$23.59B$23.00B$23.53B$23.22B$23.43B
Low$22.17B$23.59B$22.07B$23.01B$22.44B$22.95B$22.65B$22.85B
High$24.01B$23.83B$23.09B$24.08B$23.48B$24.02B$23.71B$23.92B
EBITDA Avg$1.14B$1.17B$1.11B$1.16B$1.13B$1.16B$1.14B$1.15B
Low$1.09B$1.16B$1.09B$1.13B$1.11B$1.13B$1.12B$1.13B
High$1.18B$1.17B$1.14B$1.19B$1.16B$1.18B$1.17B$1.18B
EBIT Avg$955M$980M$935M$975M$951M$973M$960M$969M
Low$917M$975M$912M$951M$928M$949M$937M$945M
High$993M$985M$955M$996M$971M$993M$980M$989M
Net Income Avg$493M$630M$483M$487M$553M$645M$545M$529M
Low$481M$622M$468M$471M$536M$624M$527M$512M
High$503M$637M$497M$500M$568M$663M$559M$544M
EPS Avg$2.51$3.21$2.47$2.48$2.82$3.29$2.78$2.70
Low$2.45$3.18$2.39$2.41$2.73$3.19$2.69$2.61
High$2.56$3.25$2.53$2.55$2.90$3.38$2.85$2.77
Analysts (Rev / EPS)2 / 42 / 41 / 11 / 11 / 11 / 11 / 21 / 2

Earnings Surprises

Recent Analyst Actions

Aug 13, 2026BMO Capital
BMO Capital Reiterates Outperform Rating on Bunge (BG)
Target:$150.00
+31.9%from $113.68
Apr 30, 2026Barclays
Bunge price target raised to $150 from $145 at Barclays
Target:$150.00
+18.8%from $126.31
Mar 5, 2026Morgan Stanley
Morgan Stanley Reiterates Overweight Rating on Bunge (BG) ahead of investor day
Target:$130.00
+15.3%from $112.75
Feb 5, 2026UBS
Bunge price target raised to $145 from $108 at UBS
Target:$145.00
+23.7%from $117.23
Feb 5, 2026BMO Capital
Bunge price target raised to $130 from $110 at BMO Capital
Target:$130.00
+10.9%from $117.23
Feb 5, 2026Stephens
Bunge price target raised to $130 from $115 at Stephens
Target:$130.00
+10.9%from $117.23
Jan 21, 2026Coker Palmer
Bunge price target raised to $117 from $109 at JPMorgan
Target:$117.00
+6.3%from $110.06
Oct 27, 2025Morgan Stanley
Bunge price target raised to $95 from $83 at Morgan Stanley
Target:$95.00
-2.7%from $97.61
Oct 21, 2025Barclays
Bunge price target raised to $105 from $85 at Barclays
Target:$105.00
+8.0%from $97.25
Oct 17, 2025Stephens
Bunge price target raised to $115 from $85 at Stephens
Target:$115.00
+20.6%from $95.33
Oct 16, 2025BMO Capital
Bunge price target raised to $110 from $95 at BMO Capital
Target:$110.00
+18.2%from $93.09
Aug 12, 2025Morgan Stanley
Bunge price target raised to $83 from $74 at Morgan Stanley
Target:$83.00
-0.2%from $83.14
Oct 30, 2024CFRA
Bunge (BG) PT Lowered to $90 at CFRA
Target:$90.00
+4.8%from $85.86
Apr 25, 2024HSBC
Bunge downgraded to Hold from Buy at HSBC
Target:$105.00
+0.9%from $104.06
Apr 24, 2024Coker Palmer
Bunge (BG) PT Raised to $122 at Citi
Target:$122.00
+15.3%from $105.79
Dec 14, 2022UBS
UBS Initiates Coverage On Bunge with Buy Rating, Announces Price Target of $133
Target:$133.00
+40.8%from $94.47
May 2, 2022Morgan Stanley
Morgan Stanley Maintains Equal-Weight on Bunge, Raises Price Target to $120
Target:$120.00
+3.7%from $115.75
Apr 28, 2022Credit Suisse
Credit Suisse Maintains Outperform on Bunge, Raises Price Target to $140
Target:$140.00
+20.3%from $116.41
Apr 28, 2022BMO Capital
BMO Capital Maintains Outperform on Bunge, Raises Price Target to $144
Target:$144.00
+21.0%from $118.96
Apr 25, 2022Barclays
Barclays Maintains Overweight on Bunge, Raises Price Target to $135
Target:$135.00
+16.8%from $115.56
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.